Sponsor pipeline

Sun Yat-sen University clinical trial pipeline

Get alerts when Sun Yat-sen University's trials change

556 active trials 305 recruiting 114 Phase 3 43 disease areas 27 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-02

What changed in the last 30 days

2026-09-16
Primary completion pushed: 2026-12 → 2030-12-31
Completion pushed: 2026-12 → 2030-12-31
NCT02989298 Peritoneal Dialysis Registration System (PERSIST)
2026-09-16
Primary completion pushed: 2026-12 → 2029-12
Completion pushed: 2027-12 → 2029-12
NCT03001921 Wise Practice of Chinese Hemodialysis (WISHES)
2026-09-16
Primary completion pushed: 2026-12 → 2029-12
Completion pushed: 2026-12 → 2029-12
NCT03001947 IgA Nephropathy Registration Initiative of High Quality (INSIGHT)
2026-09-16
Primary completion pushed: 2026-12 → 2029-12
Completion pushed: 2028-12 → 2029-12
NCT03001934 Super Chinese Nephrotic Syndrome Registration System (SUCCESS)
2026-09-16
Primary completion pushed: 2026-12 → 2029-12
Completion pushed: 2026-12 → 2029-12
NCT03001973 High Quality Evidence of Chinese Lupus Nephritis (HELP)
2026-10-01
Primary endpoint(s) modified
Enrollment closed, study ongoing
NCT06630780 Reduction of Postoperative Radiotherapy in Head and Neck Squamous Cell Carcinoma
2026-09-18
Recruitment opened
NCT07622771 Neoadjuvant Radiotherapy Combined With NALIRIFOX and Adebrelimab in pMMR/MSS Locally… · Phase 2
2026-09-17
Enrollment closed, study ongoing
Final enrollment: 44 participants (planned 50)
Completion pushed: 2026-12 → 2028-12
NCT05949944 Linperlisib in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma · Phase 1/2
2026-09-16
Enrollment closed, study ongoing
Primary completion moved earlier: 2028-08-31 → 2026-12-31
NCT06647732 Zanubrutinib Plus Rituximab as Front-line Treatment for Mucosa-associated Lymphoid Tissue… · Phase 2
2026-09-05
Trial completed
NCT05027386 Apatinib Mesylate Combined With IT Regimen for the Treatment of Recurrent or Refractory… · Phase 1/2
2026-09-06
Trial status changed: Recruiting → Unknown
NCT01649830 Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma · Phase 3
2026-09-06
Trial status changed: Not Yet Recruiting → Unknown
NCT06574763 Neoadjuvant RC48 Plus Carboplatin for HER2-expressing Advanced Ovarian Cancer · Phase 2
2026-09-06
Trial status changed: Not Yet Recruiting → Unknown
NCT06505278 The Impact of Medication Timing Adjustment on the Effect of Novel Hormonal Therapy · Phase 2
2026-09-06
Trial status changed: Recruiting → Unknown
NCT05572983 Phase Ⅱ Study of Chidamide in Combination With CHOP in Previously Untreated Peripheral… · Phase 2
2026-09-06
Trial status changed: Recruiting → Unknown
NCT06195202 Serum Estradiol (E2) Levels in Breast Cancer Patients During Endocrine Therapy by High…
2026-09-06
Trial status changed: Recruiting → Unknown
NCT06170021 Occurrence of Radiation-induced Otitis Media in Nasopharyngeal Carcinoma Patients After…
2026-09-06
Trial status changed: Recruiting → Unknown
NCT06070636 bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular…
2026-09-06
Trial status changed: Recruiting → Unknown
NCT05116579 Circulating Tumor DNA (ctDNA) Monitoring in the Assessment and Prediction of the Efficacy…

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-09-29 NCT07847359 Cryoablation Combined With Hepatic Arterial Infusion of Iparomlimab and Tuvonralimab… Phase 2 Recruiting
2026-09-18 NCT07827066 Multi-Theory Model-Based AI Agent Intervention for Smoking Cessation in Early-Stage… Not Yet Recruiting
2026-09-17 NCT07824856 Local Ablation Plus Systemic Therapy for Metachronous Liver and/or Lung Oligometastases… Phase 2 Not Yet Recruiting
2026-09-09 NCT07809893 Ivosidenib Plus mFOLFOXIRI and Celecoxib for BRAF-targeted Therapy-refractory BRAF… Phase 2 Recruiting

Active trials by phase

Early Phase 1
2
Phase 1
12
Phase 1/2
20
Phase 2
237
Phase 2/3
12
Phase 3
102
Phase 4
4
Not charted: 167 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials top 25 of 556

NCT IDTitleConditionStatusUpdated
Phase 4
NCT06624696 Inhaling Penehyclidine to Prevent Perioperative Respiratory Adverse Events in Children at… Respiratory Hypersensitivity Recruiting 2026-04-14
NCT06437288 Hematoporphyrin Photodynamic Therapy for Esophageal Cancer Esophageal Cancer Enrolling by Invitation 2026-05-22
NCT06770088 Vunakizumab in Adults with Spondyloarthritis Spondyloarthritis (SpA) Not Yet Recruiting 2025-01-13
NCT02785380 Laparoscopic Surgery VS RFA for Recurrent HCC Hepatocellular Carcinoma Not Yet Recruiting 2016-06-02
Phase 3
NCT07381660 SBRT Versus Surgical Resection for Small HCC Hepatocellular Carcinoma (HCC) Recruiting 2026-09-01
NCT07796789 Prophylactic Nanocrystalline Megestrol Acetate Versus Placebo for… Nasopharyngeal Cancinoma (NPC) Recruiting 2026-09-01
NCT07235319 PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Salvage Locoregional… Nasopharangeal Cancer Recruiting 2026-08-28
NCT07661771 Individualized Primary Clinical Target Volume Based on Margin Expansion for… Non-metastatic Nasopharyngeal Carcinoma Recruiting 2026-08-19
NCT07543536 Megestrol Acetate for Fatigue Management in T-DXd Treated Breast Cancer Advanced/Metastatic Breast Cancer Recruiting 2026-08-14
NCT07706985 Efficacy and Safety of TPC Induction Chemotherapy Combined With Nimotuzumab and… Nasopharyngeal Carcinoma (NPC) Recruiting 2026-07-16
NCT07705243 Efficacy and Safety of Becotatug Vedotin (MRG003) Combined With Anti-PD1 as Maintenance… Nasopharyngeal Cancinoma (NPC) Recruiting 2026-07-15
NCT07477626 Radiotherapy After Prostatectomy for Node Positive Prostate Cancer Prostate Cancer (Post Prostatectomy) Recruiting 2026-06-16
NCT03303495 A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC Colorectal Neoplasms Recruiting 2026-06-05
NCT04436965 Effect of Standard Nutrition Therapy on Nutritional Status and Prognosis in… Nasopharyngeal Carcinoma Recruiting 2026-05-11
NCT05340491 Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised… Nasopharyngeal Carcinoma Recruiting 2026-05-11
NCT05941741 IC Plus Low-dose Radiation Plus Cadonilimab in LANPC Nasopharyngeal Carcinoma Recruiting 2026-05-11
NCT03907826 PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma… Recurrent Nasopharyngeal Carcinoma Recruiting 2026-05-07
NCT07311772 Prevention and Treatment of Radiation-Induced Oral Mucositis in NPC With Houyanqing Oral… Nasopharyngeal Cancinoma (NPC) Recruiting 2026-05-07
NCT04944914 Camrelizumab Plus Stereotactic Body Radiotherapy vs Camrelizumab Alone For… Nasopharyngeal Carcinoma Recruiting 2026-04-30
NCT05357846 PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally… Squamous Cell Esophageal Carcinoma Recruiting 2026-04-30
NCT07528209 Neoadjuvant CAPOX With or Without Pucotenlimab Plus Selective Radiotherapy for Locally… Rectal Cancer Recruiting 2026-04-30
NCT07177794 Consolidation of Toripalimab and Capecitabine After Chemoradiotherapy in ESCC Esophageal Cancer Recruiting 2026-04-21
NCT06545747 Adaptive Hypofractionated Radiotherapy for Locally Advanced NSCLC Based on Dynamic… Non-small Cell Lung Cancer Recruiting 2026-04-06
NCT07481786 Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With… Lung Adenocarcinoma Recruiting 2026-04-06
NCT07125755 Comparing Postoperative Adjuvant Cisplatin Concurrent Chemoradiotherapy With Adjuvant… Squamous Cell Cancer of Head and Neck (SCCHN) Recruiting 2026-03-23
See all 556 active Sun Yat-sen University trials with filters →

Disease areas by active trials, top 10 of 43

Head & Neck Cancer (121) · Colorectal Cancer (69) · Liver Cancer (47) · Lung Cancer (44) · Non-Small Cell Lung Cancer (NSCLC) (38) · Breast Cancer (25) · Non-Hodgkin Lymphoma (23) · Esophageal Cancer (16) · DLBCL (11) · Sarcoma (11)

Get alerts when Sun Yat-sen University's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free